Literature DB >> 3035501

Dual tissue-specific expression of apo-AII is directed by an upstream enhancer.

C S Shelley, F E Baralle.   

Abstract

Apolipoprotein-AII (apo-AII) is one of a family of evolutionarily related proteins which play a crucial role in lipid transport and metabolism. The serum levels of human apo-AII have been shown to be inversely correlated to the incidence of coronary heart disease and its expression to be limited to the liver and intestine. Here we demonstrate that this dual tissue-specificity involves DNA sequences located in a 259 bp region centred 782 bp upstream from the transcription initiation site. These sequences function in an orientation-independent manner and are absolutely required for transcription from the apo-AII promoter. The regulatory region contains sequences which are homologous to the apo-AI, beta-globin and immunoglobulin gene promoters and to the immunoglobulin heavy-chain enhancer.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3035501      PMCID: PMC340783          DOI: 10.1093/nar/15.9.3801

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  84 in total

1.  The removal of cholesterol from aortic smooth muscle cells in culture and Landschutz ascites cells by fractions of human high-density apolipoprotein.

Authors:  Y Stein; M C Glangeaud; M Fainaru; O Stein
Journal:  Biochim Biophys Acta       Date:  1975-01-24

2.  Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men.

Authors:  G G Rhoads; C L Gulbrandsen; A Kagan
Journal:  N Engl J Med       Date:  1976-02-05       Impact factor: 91.245

3.  Interaction between high density and low density lipoproteins uptake and degradation by cultured human fibroblasts.

Authors:  N E Miller; D B Weinstein; T E Carew; T Koschinsky; D Steinberg
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

4.  High-density lipoproteins in myocardial infarction survivors.

Authors:  J J Albers; M C Cheung; W R Hazzard
Journal:  Metabolism       Date:  1978-04       Impact factor: 8.694

5.  A new method for sequencing DNA.

Authors:  A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

6.  Ribonucleic acid isolated by cesium chloride centrifugation.

Authors:  V Glisin; R Crkvenjakov; C Byus
Journal:  Biochemistry       Date:  1974-06-04       Impact factor: 3.162

7.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

8.  Molecular weights of some HeLa ribosomal RNA's.

Authors:  E H McConkey; J W Hopkins
Journal:  J Mol Biol       Date:  1969-02-14       Impact factor: 5.469

9.  Markers of neoplastic transformation in epithelial cell lines derived from human carcinomas.

Authors:  C J Marshall; L M Franks; A W Carbonell
Journal:  J Natl Cancer Inst       Date:  1977-06       Impact factor: 13.506

10.  Alcohol and blood lipids. The cooperative lipoprotein phenotyping study.

Authors:  W P Castelli; J T Doyle; T Gordon; C G Hames; M C Hjortland; S B Hulley; A Kagan; W J Zukel
Journal:  Lancet       Date:  1977-07-23       Impact factor: 79.321

View more
  8 in total

1.  Retinoids increase human apolipoprotein A-11 expression through activation of the retinoid X receptor but not the retinoic acid receptor.

Authors:  N Vu-Dac; K Schoonjans; V Kosykh; J Dallongeville; R A Heyman; B Staels; J Auwerx
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

2.  Two regulatory elements of similar structure and placed in tandem account for the repressive activity of the first intron of the human apolipoprotein A-II gene.

Authors:  J P Bossu; F L Chartier; J C Fruchart; J Auwerx; B Staels; B Laine
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

3.  The proximal element of the human apolipoprotein A-II promoter increases the enhancer activity of the distal region.

Authors:  J M Lacorte; E Fourniat; D Pastier; J Chambaz; A Ribeiro; P Cardot
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

4.  Identification of an enhancer-like element in the 5' flanking region of the rat apolipoprotein A-I gene.

Authors:  Y S Chao; X H Ding; P H Dai; T J Wu; T C Pan; Q L Hao; T T Yamin
Journal:  Nucleic Acids Res       Date:  1988-07-25       Impact factor: 16.971

5.  B-cell control region at the 5' end of a major histocompatibility complex class II gene: sequences and factors.

Authors:  A Dorn; H J Fehling; W Koch; M Le Meur; P Gerlinger; C Benoist; D Mathis
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

6.  Interaction of DNA-binding proteins with the tissue-specific human apolipoprotein-AII enhancer.

Authors:  M A Lucero; D Sanchez; A R Ochoa; F Brunel; G N Cohen; F E Baralle; M M Zakin
Journal:  Nucleic Acids Res       Date:  1989-03-25       Impact factor: 16.971

7.  Association of a polymorphism in the Apo AI gene promoter with hyperalphalipoproteinemia.

Authors:  F Pagani; G A Giudici; F E Baralle; C Vergani
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

8.  Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor.

Authors:  N Vu-Dac; K Schoonjans; V Kosykh; J Dallongeville; J C Fruchart; B Staels; J Auwerx
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.